Pharmaceutical companies are adopting direct-to-consumer drug sales, bypassing insurers and PBMs. This strategy impacts drug pricing, patient out-of-pocket costs, and insurance market dynamics in the U.S.
A detailed debate on the proposal for a U.S. government health insurance plan competing with private insurers, highlighting key perspectives from experts Jacob Hacker and David Goldhill.
Explore how UnitedHealth Group's vertical integration of insurance, PBM, and provider services enhances managed care efficiency and influences U.S. healthcare costs.
The U.S. health insurance market is projected to grow to $2.13 trillion by 2030, driven by rising healthcare costs, chronic diseases, and digital adoption. Employer and individual plans evolve amid regulatory and technological shifts.
Exploring how proposed federal budget cuts of $880 billion over the next decade might affect the financial health and service availability at rural hospitals across the U.S.
